Tobacco smoking and nicotine dependence: biological basis for pharmacotherapy from nicotine to treatments that prevent relapse.
Gold
M S
MS
Department of Neuroscience, University of Florida Brain Institute, Gainesville, USA.
Herkov
M J
MJ
D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D004298:Dopamine / Q000502:physiology; D006801:Humans; D009538:Nicotine / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use; D009714:Nucleus Accumbens / Q000502:physiology; D011109:Polymethacrylic Acids / Q000627:therapeutic use; D011145:Polyvinyls / Q000627:therapeutic use; D012008:Recurrence; D012907:Smoking / Q000503:physiopathology*; D016540:Smoking Cessation; D000074606:Smoking Prevention; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy* / Q000209:etiology; D061485:Tobacco Use Cessation Devices; D014029:Tobacco Use Disorder / Q000503:physiopathology* / Q000517:prevention & control; D017211:Treatment Failure
D000697:Central Nervous System Stimulants; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D009538:Nicotine; D004298:Dopamine